AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Headline
The Department of Health and Human Services’ Office for Civil Rights Nov. 16 finalized changes to its HIPAA privacy rule standards, with the purposes of…
Headline
In comments provided Nov. 16 to majority and minority leaders of the House and Senate, the AHA requested Congress to act on key priorities for hospitals and…
Headline
The Department of Labor Nov. 16 proposed changes to the Permanent Labor Certification program, or PERM, which generally requires employers seeking to sponsor…
Headline
The Department of Labor released an enforcement alert Nov. 13 to employers and health plan fiduciaries to ensure that plan participants and beneficiaries are…
Headline
An FBI report released Nov. 13 details actions by cyber actors weaponizing ARTEX, an open-source, large language model-driven agentic artificial intelligence…
Headline
The AHA and its co-plaintiffs Nov. 16 filed a reply brief urging a federal court to block implementation of the Health Resources and Services Administration’s…